The Proof with Simon Hill avatar

Dexa/The Proof with Simon Hill

Learn more

Innovative Lipid Treatments

Thomas discusses the potential benefits of adding a PCSK nine inhibitor to lipid-lowering treatments, despite lack of FDA indication. He emphasizes the importance of personalized medicine and achieving guideline-prescribed LDL cholesterol goals.
  • In this clip

  • From this podcast

    The Proof with Simon Hill avatar

    The Proof with Simon Hill

    New heart disease test you should order | Thomas Dayspring, Md

  • Related Questions

    • Should I use statins or PCSK9 inhibitors to lower LDL and apoB as discussed in the episode Dr. Peter Attia on Longevity Drugs, Alzheimer's Disease, and The 3 Most Important Levers to Pull and the clip Cholesterol Breakthroughs?

    • Should I use statins or PCSK9 inhibitors to lower LDL and apoB as discussed in the episode Dr. Peter Attia on Longevity Drugs, Alzheimer's Disease, and The 3 Most Important Levers to Pull and the clip Cholesterol Breakthroughs?

    • Should I use statins or PCSK9 inhibitors to lower LDL and apoB as discussed in the episode Dr. Peter Attia on Longevity Drugs, Alzheimer's Disease, and The 3 Most Important Levers to Pull and the clip Cholesterol and Health?

Built by
Charlie AI
© 2024 The Proof with Simon HillTermsPrivacySupport